scholarly journals Beta-blockers in chronic heart failure in elderly patient

2009 ◽  
Vol 3 (2) ◽  
pp. 89-95
Author(s):  
Alberto De Bernardi
Keyword(s):  
Heart Failure ◽  
Elderly Patient ◽  
Chronic Heart Failure ◽  
Elderly Patients ◽  
Observational Studies ◽  
Randomized Trials ◽  
Beta Blockers ◽  
Young Patients ◽  
Heart Failure Treatment ◽  
Failure Treatment

Chronic heart failure (CHF) is a common and disabling condition with morbidity and mortality that increase dramatically with advancing age. There are evidences, from both randomized trials and observational studies, that suggest that beta-blockers are effective and well tolerated in elderly as well as in young patients. Nonetheless in clinical practice they are substantially underutilized in elderly patients. The article underlines peculiarities of chronic heart failure treatment with beta-blockers in elderly patients, with a review of the most important published trials.

Elderly patients with systolic dysfunction and severe heart failure benefit from an aggressive heart failure treatment program

1999 ◽  
Vol 5 (3) ◽  
pp. 79
Author(s):  
John S. Golden ◽  
Catherine Chelimsky-Fallick ◽  
Donna J. Mateski ◽  
Colleen M. Healey ◽  
Sharon R. Josephson ◽  
...  
Keyword(s):  
Heart Failure ◽  
Elderly Patients ◽  
Treatment Program ◽  
Systolic Dysfunction ◽  
Severe Heart Failure ◽  
Heart Failure Treatment ◽  
Failure Treatment

scholarly journals Adherence to European Society of Cardiology Heart Failure Treatment Guideline in Haji Adam Malik General Hospital Medan

2020 ◽  
Vol 3 (1) ◽  
pp. 59-64
Author(s):  
Ardy Putra Wirtanto ◽  
Andika Sitepu
Keyword(s):  
Heart Failure ◽  
European Society ◽  
Treatment Guidelines ◽  
Beta Blockers ◽  
Treatment Guideline ◽  
Public Health Problem ◽  
Cross Sectional ◽  
Heart Failure Treatment ◽  
Failure Treatment ◽  
European Society Of Cardiology

Background. Heart failure is a public health problem and the main cause of morbidity and mortality in the world. The goal of the therapy is to reduce symptoms, prevents rehospitalization and increases survivability. Objective. To evaluate the adherence to the European Society of Cardiology for heart failure treatment at H. Adam Malik Medan hospital. Methods. The study was descriptive observational cross sectional design with medical record data of heart failure at H. Adam Malik Hospital, using consecutive sampling method. The adherence of guidelines was assessed by: (1) drug prescribing (“yes” or “no”), and (2) guideline adherence indicator (GAI), both GAI-3 or GAI-5, by calculating the proportion as the number of drugs prescribed by number of drugs indicated to the ESC guidelines. Results. From research, the predominant GAI-3 and GAI-5 were High, which were 54.9% and 59.5%, respectively. The recommended drug used based on indications were ACE-i / ARB (89.1%), beta-blockers (83.4%), MRA (73.6%), diuretics (93.7%), and digitalis (20,8%). Conclusion. The predominant category in adherence to the ESC heart failure treatment guidelines based on GAI-3 and GAI-5 is High.

A decade of developments in chronic heart failure treatment: a comparison of therapy and outcome in a secondary and tertiary hospital setting

2011 ◽  
Vol 101 (1) ◽  
pp. 1-10 ◽  
Author(s):  
Jennifer Franke ◽  
Christian Zugck ◽  
Jan Sebastian Wolter ◽  
Lutz Frankenstein ◽  
Matthias Hochadel ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Hospital Setting ◽  
Tertiary Hospital ◽  
Heart Failure Treatment ◽  
Failure Treatment
Sign in / Sign up

Export Citation Format

Share Document